ASX Announcements
Memphasys is committed to providing shareholders with complete, up-to-the-minute information about the Company. Contact, stock, and corporate information can be found in this section of the website and on the Australian Securities Exchange.
4 December 2023 – 2023 Rights Issue Prospectus (disclaimer)
30 November 2023 – Executive transition and Capital Raise
31 October 2023 – Quarterly Activity Report and Appendix 4C
26 September 2023 – Investor Presentation – Human & Animal Programs
15 September 2023 – 10 new live births in India (Felix™)
14 August 2023 – Initial Felix™ order – Vitrolife Japan
7 August 2023 – Exclusive Japanese distribution with Vitrolife
28 July 2023 – Quarterly Activities / Appendix 4C
13 July 2023 – New Patents granted for Felix System
6 June 2023 – Best method to treat cryopreserved semen
28 April 2023 – Quarterly Activities / Appendix 4C
5 April 2023 – Investor presentation April 2023
3 April 2023 – First commercial sale & first baby using Felix
30 March 2023 – Operations Director appointed
28 February 2023 – Director of BusDev appointed
24 February 2023 – Half Yearly Report and Accounts
7 February 2023 – KOL testings show Felix > DGC
31 January 2023 – Dec Quarterly Activities / 4C